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This thesis explores a new class of hierarchical containers that are formed via single-step 
assembly, and at a later time, self-destruct due to their packaged contents. These 
containers are spherical capsules formed by electrostatic complexation of the anionic 
biopolymer, gellan gum with the cationic biopolymer, chitosan. The capsules are termed 
“motherships”, and are engineered to carry a payload of much smaller containers, i.e., 
nanoscale vesicles (“babyships”), within its lumen. By also packaging an enzyme, 
chitosanase, inside the capsule, we create “motherships” that self-destruct, releasing their 
payload of “babyships” in a pulsatile manner. The timescale for self-destruction can be 
engineered based on the internal concentration of enzyme. The “motherships” are stable 
when stored in a freeze-dried form and can be readily dispersed into buffer solutions at a 
later time, whereupon their “internal clock” for self-destruction is initiated. The above 
concept could be useful for the controlled release of a variety of payloads including 
drugs, biological therapeutics, cosmetics, or flavor ingredients.  
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Chapter 1: INTRODUCTION & OVERVIEW 
 
A major research topic in academia and the pharmaceutical industry has been the 
delivery of drugs. With regard to drug carriers, two popular types of such vehicles are 
vesicles and capsules. Vesicles (also termed liposomes) are typically nanoscale structures 
formed by the self-assembly of amphiphilic molecules such as lipids or surfactants.1, 2 
The inner core of vesicles is an aqueous solution and a wide range of molecules can be 
encapsulated within this core. However, vesicles have the disadvantage that they are 
vulnerable and can be easily broken down in vivo due to the fact that they are held 
together by relatively weak bonds. On the other hand, capsules are structures having a 
liquid core surrounded by a solid shell (typically made of polymers or inorganic 
molecules). Capsules are typically much larger (microscale or milliscale), but they are 
much more robust compared to vesicles. Once again, the core of capsules can hold a 
variety of drugs, and the slow permeability of the packaged drugs across the shell can be 
used to deliver the drugs in a sustained manner.  
 
This thesis seeks to create a hybrid of the above two structures, i.e. capsules 
containing vesicles. Such a hybrid would be attractive as a drug delivery vehicle, as it 
offers to combine the advantages of both whilst minimizing the drawbacks of each.3 We 
term these hybrids as “mothership” capsules which are hierarchical structures containing 
encapsulated vesicles or “babyships”. An overview of this type of structure is shown in 
figure 1.1. By including nano-sized babyships within motherships, we ensure that 
capsules protect susceptible vesicles from external factors. Motherships can be made 
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more versatile by including additional drugs within its lumen. We will demonstrate a 
single-step method to form mothership capsules by electrostatic complexation of 
oppositely charged polymers in the presence of vesicles. Our method employs mild 




Figure 1.1. Concept of “mothership” capsule with internalized “babyships” and payload. 
 
A key challenge in drug delivery revolves around the mechanisms employed for 
triggering the delivery of the drug from the vehicle. Changes in the chemical, physical 
and biological environment have been exploited to trigger vehicles to release drugs.4 In 
this vein, it is of interest to design “mothership” capsules so that they respond to external 
triggers. For example, a trigger could cause the capsule shell to open up, thereby 
releasing the internalized vesicles for delivery to a target. Alternately, another concept is 
to design self-destructing vehicles. These would offer the advantage of being immune to 
external stimuli while relying on an internal mechanism to trigger the release of drugs.  
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The latter concept is explored here and we make self-destructing mothership capsules by 
including within the capsule an enzyme that is capable of degrading the capsule shell, as 
shown in figure 1.2. In this way, we can design a mothership that self-destructs within a 
given time, thus releasing babyships into the surrounding environment, each carrying its 
own distinct payload. The degradation time of motherships is shown to be controllable by 
the concentration of encapsulated enzyme. The capsules can be stored as a dry powder, 
and when they are hydrated, the internal clock for destruction is begun. If the capsules 
have targeting moieties such as antibodies on their surface, they can reach a specific 
location before the self-destruction is initiated. This can ensure release of the babyships at 
the desired location.  
 
 
Figure 1.2. Self destruction of mothership capsule with internalized enzyme for timed 
release of babyship vesicles  
 
We envision self-destructing mothership capsules as being analogous to “ticking 
time bombs” with an internal trigger to deliver encapsulated payload at a pre-determined 
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time. This concept of timed release of drug-loaded nano-vector from a larger container 
can be useful to a variety of applications such as delivering not only drugs and biological 
therapeutics, but also cosmetics, fertilizers, chemicals and flavor ingredients. 
 
 5 
Chapter 2: BACKGROUND 
 
In this chapter, we discuss basic aspects pertaining to the components of the mothership 
capsules to be studied in Chapter 3. The main components of the capsules are the 
biopolymers, chitosan and gellan gum, and the structures encapsulated in the capsules 
include vesicles and enzymes. We also provide a description of the process for forming 
capsules and specifically the mothership capsules.   
 
2.1. BIOPOLYMERS 
Polymers are macromolecules formed from repeating structural units. Polymers 
having biological origin are called biopolymers.5 For the purposes of this study, we will 
focus on biopolymers that have specific charge and render viscosity to water by forming 
entangled networks or gels.  
        
Chitosan 
Chitosan is a linear cationic polysaccharide obtained from the N-deacetylation of 
chitin.6 Chitin is derived from the exoskeleton of crustaceans and is abundantly available 
in nature. The chitosan backbone is mostly composed of D-glucosamine (β-(1,4)-2-
deoxy-2-amino-D-glucopyranose) sugars, with a small fraction of N-acetyl-D-
glucosamine (β-(1,4)-2-deoxy-2-acetamido-D-glucopyranose) sugars from the parent 
chitin. Chitosan is soluble in water under acidic conditions of pH < 6.5, as the amine 
groups on the parent chain are ionized and the structure acts as a cationic polymer. The 
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structures of these sugars are shown in Figure 2.1. Chitosan is biocompatible, 







Figure 2.1. Structures of the parent sugars in (a) chitin and (b) chitosan. The N-acetyl-D-
glucosamine sugar in chitin is deacetylated to give the D-glucosamine sugar in chitosan. 
 
Gellan Gum 
Gellan gum is an anionic polymer that is derived from the bacterium 
pseudomonas elodea.7 It is a water soluble polymer and has a repeat unit of the 
tetrasaccharide D-glucose, D-glucuronic acid, D-glucose, and L-rhamnose. These units 
are connected by α–(1,3) glycosidic bonds. Because of the carboxylate groups, gellan 
gum is an anionic polymer. Gellan gum is biocompatible, biodegradable and non-toxic, 
which makes it suitable for drug delivery applications. 
 
 


























Vesicles are containers formed by the self assembly of amphiphilic molecules in 
water.1 Amphiphilic molecules such as phospholipids or surfactants are composed of a 
hydrophilic head and hydrophobic tails. These molecules self assemble in water to form 
bilayers with hydrophilic heads exposed to water protecting the hydrophobic moiety as 
shown in figure 2.3. Folding of the bilayer gives vesicle structures having diameters in 
the range of 30 nm to 30 µm. Vesicles are known to encapsulate a variety of compounds 




Figure 2.3. Structure of vesicles formed by the self-assembly of amphiphiles. The vesicle 
is formed by the folding of an amphiphilic bilayer 5-10 nm in thickness. 
 
Lipids are amphiphiles of biological origin and typically have two hydrophobic 
tails and one hydrophilic head.2 Vesicles formed from lipids are known as liposomes. 
Liposomes have been known to be taken up by tumor cells and are useful drug delivery 
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agents. Research in this field has involved chemically modifying liposomes making them 
sterically stabilized to improve their targetability and functionality. Recently, cationic 
liposomes have found applications in gene delivery application.8 
 
2.3. POLYMER CAPSULES 
Capsules may be defined as structures having a liquid core enclosed within a solid 
shell. They have sizes ranging from a few microns to several millimeters and can be 
prepared using various techniques such as emulsification, layer-by-layer assembly, 
internal phase separation and coacervation.4 The shell thickness determines the 
mechanical integrity of capsules.  
 
2.3.1. CAPSULE FORMATION 
The method we use for capsule formation involves the coacervation process. This 
method utilizes polyelectrolyte complexation of oppositely charged polymers.  We use 
chitosan as the cationic polymer and gellan gum as the anionic polymer in the 
coacervation process.9 Chitosan solution is added drop-wise to a bath containing a 
solution of gellan gum (or vice versa) to form capsules, as shown in Figure 2.4. This 
forms a poly-ion network at the capsule shell which traps the liquid within. The size of 
the capsules is equal to the size of the generating drop. Smaller capsule sizes of the order 
of microns can be generated by employing techniques such as atomization or 
microfluidics. Note also that any payload included with the chitosan solution becomes 
encapsulated in the capsules. Thus capsules with suitable payload can be generated in a 
simple, single step under mild conditions.    
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2.3.2. MOTHERSHIP CAPSULES 
Mothership capsules are hierarchical structures with babyship vesicles 
internalized in them. Encapsulation of vesicles within larger capsules has been studied 
before and proven useful for delayed drug delivery.3, 10 For our application, we create 
mothership capsules by modifying the coacervation technique. Vesicles are mixed with 
the anionic gellan gum solution to form the feeder solution as the first step. Feeder 
solution is then added drop wise to a bath of cationic chitosan solution. After a fixed 
incubation time, mothership capsules are formed that contain internalized babyship 
vesicles. Electrostatic interactions of oppositely charged polymers stabilize the capsule 
shell. Capsules are stable under mechanical stirring and are stored in buffer solutions. 
 
Figure 2.4. Preparation of mothership capsules (a) PC liposomes are mixed with anionic 
gellan gum solution to form feeder; (b) Feeder solution is added drop wise to cationic 
chitosan solution; (c) Mothership capsules are formed by electrostatic complexation of 
oppositely charged polymers at drop interface with internalized liposomes. 
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2.3.3. TRIGGERED CAPSULE DEGRADATION 
Capsules can be induced to break open to release internalized contents in response 
to physical, chemical or biological stimuli. Previously, light activated capsules have been 
reported which degrade on exposure to light of specific wavelength.11 Capsules have also 
been designed to degrade in response to changes in pH or ionic strength.12, 13 Ultrasound 
and magnetic fields have also been used as stimuli to rupture capsules.14, 15 For our 
application, we employ a biological stimulus to rupture capsules. More specifically, we 
utilize enzymes to degrade our capsules and deliver payload. 
 
2.4. ENZYMATIC DEGRADATION OF BIOPOLYMERS 
 Enzymes are biocatalysts that perform a precise reaction on a specific substrate.16 
They offer the advantages of specificity and control under mild conditions. We employ 
enzymatic degradation to break down our mothership capsules. As mentioned earlier, we 
utilize biopolymers to form our capsules. By choosing an appropriate enzyme, we can 
selectively degrade the polymers in the capsule shell. In particular, we use chitosanase, an 
enzyme that catalyzes the degradation of polymeric chitosan into oligomers.17 
Chitosanase is derived from various sources such as bacteria, fungi and plants. Some 
other enzymes capable of degrading chitosan are chitinase, hemicellulase and lysozymes. 
However, chitosanases have high specificity and activity in cleaving the β-(1,4) linkages 
between the D-glucosamine units in chitosan, as shown in Figure 2.5b, making them the 
optimal choice for our application. The final products obtained from chitosan hydrolysis 
are dimers and trimers, accompanied by a very limited quantity of monomers.18 Enzyme 
activity is defined in term of units where one unit of chitosanase will liberate 1.0 
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micromole of reducing sugar (measured as D-glucosamine equivalents) from chitosan per 
minute at pH 5.5 and 37°C. 
 
 
Figure 2.5. Enzymatic degradation of biopolymers: (a) Enzymatic degradation of 





Chapter 3: SELF-DESTRUCTING MOTHERSHIP CAPSULES: 
SYNTHESIS AND CHARACTERIZATION 
 
3.1. INTRODUCTION 
In Chapter 3, we explore the synthesis of “mothership” capsules, which are 
microscale (or larger) container structures that contain much smaller (nanoscale) 
secondary containers. The nanoscale containers of interest here are vesicles, which are 
well-known for their ability to encapsulate hydrophilic solutes in their aqueous core. The 
synthesis of polymeric capsules containing nanoscale vesicles has been explored by a few 
research groups over the past two decades.3, 10 An advantage of this type of structure is 
that it can prolong the release of solute. That is, solutes entrapped in the vesicles will 
have to first leak out through the bilayer of the vesicles into the lumen of the capsules and 
thereafter out to the external solution through the capsule shell. The presence of two 
transport resistances – from the vesicle bilayer and the capsule shell – serves to extend or 
prolong the release of solute.  
 
A second and more important aspect of our work is that we seek to make our 
mothership capsules self-destruct after a period of time due to encapsulated enzyme. To 
our knowledge, there have been only a few studies that have attempted to create self-
destructing capsules.4, 19  Geest et al. designed self-rupturing microcapsules composed of 
a dextran-based microgel coated with a membrane of polyelectrolyes by layer-by-layer 
(LbL) deposition.20, 21 The microgel was engineered such that it underwent degradation 
on hydration, which increased the internal osmotic pressure, leading to rupture of the 
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capsule membrane and release of internalized contents. Self-degrading capsules were also 
designed by Borodina et al. by incorporating enzymes (proteases) within the lumen of 
polymer microcapsules prepared by the LbL technique.22 The enzymes were loaded into 
calcium carbonate particles, and these were embedded within the capsules. A calcium-
chelating agent was then used to dissolve the particles and thereby release the enzymes 
within the capsule lumen. In turn, the enzymes digested the capsule shell, thus releasing 
the contents in a time-dependent manner. The above schemes for creating self-destructing 
capsules are elegant, but rather complex. For example, LbL requires a series of labor-
intensive incubation and washing steps to form the capsule shell. The use of multi-step or 
aggressive conditions for capsule preparation can also be problematic for applications 
involving the delivery of sensitive biomolecules or drugs.   
 
In our work, we demonstrate a simple, mild process to generate self-destructing 
mothership capsules. Our method uses two commercially available biopolymers, chitosan 
and gellan gum, as the precursors for our capsules. Previous studies have been carried out 
on capsules involving these polymers though none have involved encapsulating 
vesicles.23-25 We show that the capsules can be created and loaded with both enzymes and 
vesicles in a single step. The enzyme used is chitosanase, which is capable of hydrolyzing 
the chitosan and thus degrading the shell of our capsules, which leads to release of the 
internalized vesicles en masse. We also demonstrate release experiments with other 
payloads such as fluorescent microparticles. The capsules can be stored as a dry powder, 
and when they are hydrated, the internal clock is started for degradation of their shells. 
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The degradation time of motherships is shown to be controllable by the concentration of 
encapsulated enzyme and can be varied from minutes to hours.   
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3.2. EXPERIMENTAL SECTION 
Polymers 
Chitosan was obtained from Wako Pure Chemicals (product name Chitosan 1000). It is 
expected to have an average molecular weight of 1,800,000.26 As chitosan is soluble only 
under acidic conditions, 0.2 M acetic acid was used to dissolve it. Gelrite® gellan gum 
was obtained from Sigma Aldrich and its molecular weight was specified by the 
manufacturer to be 1,000,000. Gellan gum solutions were prepared in deionized (DI) 
water by heating up to 60°C. 
  
Vesicles 
The phospholipid L-α-phosphatidylcholine (PC) was purchased from Avanti Polar Lipids 
Inc. Liposomes were prepared by an extrusion method, as recommended by the 
manufacturer. Briefly, dried films of the lipids were hydrated under moderate stirring. 
They were freeze-thawed five times, and then passed through two double-stacked 
polycarbonate membrane filters (100 nm pores) using a Lipex pressurized extrusion 
system. This ensured liposomes of size approximately 100 nm, which was confirmed by 
dynamic light scattering experiments. The fluorescent lipid, 1,1′-Dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI) was obtained from Sigma Aldrich. 
 
Enzymes and Other Chemicals 
Chitosanase from Streptomyces species was obtained from Sigma Aldrich with activity 
of 18 units/mg and stored in 50% glycerol solution containing 100 mM sodium acetate at 
pH 5. Chitosanase from streptomyces species have a reported molecular mass in the 
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range of 30-35 KDa.17 Carboxylate-modified polystyrene beads (2 µm, fluorescent green) 
were obtained from Sigma Aldrich.  
 
Dynamic Light Scattering 
A Photocor-FC instrument with a 5 mW laser light source at 633 nm was used to analyze 
the size of vesicles. Studies were done at 25°C with the scattering angle being 90°. A 
logarithmic correlator was used to obtain the autocorrelation function, which was 
analyzed by the method of cumulants to yield a diffusion coefficient for the vesicles 
analyzed. The apparent hydrodynamic radius of the vesicles was obtained from the 
diffusion coefficient through the Stokes-Einstein relationship.  
 
Microscopy 
The Zeiss Axiovert 135 TV inverted microscope equipped with Motic Image Plus 
imaging system has been used for optical microscopy. Capsules were imaged with a 2.5X 
objective. Fluorescence microscopy was carried out with excitation wavelength set at 480 
nm and emission filter at 510 nm. 
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3.3. RESULTS AND DISCUSSION 
3.3.1. MOTHERSHIP CAPSULES 
We prepared mothership capsules containing vesicles as babyships within their 
lumen by the following procedure. The method involves electrostatic complexation of the 
cationic biopolymer, chitosan and the anionic biopolymer, gellan gum.23-25 Motherships 
can be prepared with either a chitosan core and gellan shell or a gellan core and chitosan 
shell. The latter system is preferred for the self-destructing motherships and so we will 
focus on that.  
 
First, PC vesicles were prepared in DI water using the zwitterionic phospholipid, 
PC at a concentration of 1 wt%. The vesicles are expected to be unilamellar structures 
and their diameter was measured to be ~ 100 nm by DLS. Then, a gellan gum solution 
was mixed with the PC vesicles to form the feeder solution, with the gellan and PC 
concentrations in the overall mixture being 1 wt% and 0.5 wt% respectively. The feeder 
solution was then loaded into a syringe and dispensed as droplets via the tip of a 22G 
needle into a solution of chitosan (1 wt%), as shown in Figure 3.1. The droplets were 
allowed to incubate for 3 min during which the droplet was converted into a capsule, i.e., 
a shell was formed on the surface of the droplet by the electrostatic complexation of 
chitosan and gellan gum into a poly-ion network (Figure 3.1). The resulting capsules are 
the motherships and they contain the vesicles inside. They were scooped out from the 
chitosan solution and washed 3 times with DI water. They were then stored in phosphate 
buffer (pH 6) solution, where they remained stable under mechanical stirring. Note that 
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the size of the capsules can be controlled by adjusting the size of the generating drop. For 
our purposes here, we mostly have prepared relatively large capsules with sizes > 1 mm. 
Smaller capsules can be created by reducing the drop size by employing techniques such 





Figure 3.1. Preparation of self destructing mothership capsules: (a) anionic gellan gum 
mixed with PC liposomes and chitosanase forms feeder solution which is added drop 
wise to cationic chitosan; (b) spherical capsules formed by electrostatic complexation of 





3.3.2. SELF-DESTRUCTING MOTHERSHIP CAPSULES 
To generate self destructing “mothership” capsules, we modified the preparation 
method, as shown in figure 3.1. In this case, the feeder solution contained gellan gum (1 
wt%), PC liposomes (0.5 wt%), and the enzyme chitosanase (1.5 units/mL). This was 
again dispensed into a 1 wt% chitosan solution and incubated for 3 min. Thus, 
mothership capsules containing vesicles and chitosanase were prepared, and these were 
again washed and placed in pH 6 buffer for observation.    
 
 
Figure 3.2. Self-destruction of a “mothership” capsule (gellan core, chitosan shell) by 
internalized chitosanase enzyme (1.5 units/mL) at various times after placing in buffer:  
(a) initial, intact capsule shell; (b) after 4 h, showing partial degradation of the shell;     
(c) after 8 h, showing complete degradation. As the capsule degrades, the capsule releases 
its payload of vesicles into the external solution as illustrated in the cartoons below each 




The self-destructing property of the capsules could be seen both visually as well 
as by optical microscopy. Figure 3.2 presents optical micrographs showing the capsule at 
different times. Initially (Figure 3.2a), the capsule is intact and its shell uncompromised. 
After 4 h (Figure 3.2b), the shell is seen to be partially degraded. After 8 h (Figure 3.2c), 
the shell is sufficiently degraded that the capsule no longer holds its shape. The shell 
looks shriveled and by this point, the capsule has released its internal content. As 
mentioned earlier, control capsules with no encapsulated enzyme show no degradation or 
loss of mechanical integrity. Thus, it is clear that the changes in the capsule structure are 
due to the enzymatic action of chitosanase. It is well-known that chitosanase degrades 
polymeric chitosan into short oligomers. Since the capsule shell is formed by 
complexation of gellan gum chains and chitosan chains, the conversion of chitosan into 
short oligomers will result in the disruption of the shell and thereby the breakdown of the 
capsule. 
 
A key aspect of our self-destructing motherships is that the babyships, i.e., 
vesicles, are released intact into the surroundings. How can we test if the vesicles are 
released intact? For this, we show the experiment in Figure 3.3. Here, the vesicles inside 
the motherships have been formulated with the fluorescent lipid DiI. This lipid 
incorporates into the vesicle bilayer and is thus a part of each vesicle. Note that the 
vesicles have a pink color due to the DiI, and in turn, the capsules also take on this pink 
color, which shows the presence of encapsulated vesicles. Figure 3.3a shows a number of 
intact capsules in the buffer solution at time zero. Note that the pink color is confined to 
the capsules. Figure 3.3b shows the solution after 4 h. In this case, the capsules are 
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beginning to lose their integrity and in turn some of the pink color is transferred to the 
solution. Figure 3.3c shows the solution after 8 h. By this time, the capsules are fully 
degraded releasing all the vesicles to the surrounding buffer solution. We have a 
homogenous pink solution, and a DLS measurement on this solution gives an average 
diameter of structures in solution of about 100 nm, which matches the size of the original 
vesicles. This is indirect proof for the motherships being able to release intact vesicles.  
 
 
Figure 3.3. Release of DiI tagged liposomes from self destructing mothership capsules 
(chitosanase: 1.5 units/mL): (a) initially pink vesicles contained in intact capsule; (b) 
after 4 h, partial degradation of capsule with some release of pink vesicles; (c) after 8 h, 
complete degradation of capsule, pink liposomes uniformly dispersed in external buffer. 




The degradation time of the capsules can be tuned by varying the concentration of 
encapsulated enzyme. Figure 3.4 shows the results of experiments with different enzyme 
concentrations. The degradation time was assessed visually from experiments as shown 
in Figure 3.3 and it corresponds to complete degradation of capsules and uniform 
dispersion of pink liposomes in solution. (akin to Figure 3.3c). 
 
Figure 3.4. Degradation time of self-destructing “mothership” capsules as a function of 
enzyme concentration. Degradation time was observed to decrease almost exponentially 
with increase in enzyme concentration. 
 
As shown by Figure 3.4, the lowest enzyme concentration for which degradation 
was observed was 0.1 units/mL, and in this case, complete capsule degradation took 
approximately 15 h. Below this enzyme concentration, capsule degradation was not seen 
even over a period of several days. As the enzyme concentration was increased, the 
degradation time was observed to decrease almost exponentially. For 3 units/mL of 
enzyme, degradation was completed in 4 h. This may be a saturation concentration of 
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chitosanase for capsule degradation, i.e., higher enzyme concentrations did not lead to 
faster degradation. We should point out that there are a number of factors that go into 
determining degradation time apart from the kinetics of the enzymatic reaction. These 
include the rate at which enzymes diffuse through the gellan core to get to the gellan-
chitosan shell, and the rate at which pores are formed in the shell. In any case, we are 
able to tune the degradation time by about 5-fold by simply altering the enzyme 
concentration.  
 
Another experiment to monitor release of encapsulated contents was conducted 
with fluorescent polystyrene microparticles (2 µm diameter) as the payload. In this case, 
the microparticles (0.5 wt%) were mixed with chitosanase (1.5 units/mL) and gellan gum 
(1 wt%) to form the feeder solution, which was added drop wise to a chitosan solution (1 
wt%). Capsules were formed with encapsulated particles and their self-destruction in 
buffer was monitored by fluorescence microscopy. Figure 3.5a shows that initially the 
particles are localized in the interior of the capsule. A shell region having a thickness of a 
few microns surrounds the particle-filled lumen. The fluorescence signal was confined to 
the capsules; no fluorescence could be seen in the background. At the 3 h mark (Figure 
3.5b), some fluorescence could be observed in the background, indicating that the 
enzyme had partially degraded the capsule shell, allowing some particles to leak out. 
With increasing time (Figure 3.5c, d), the particles are seen to diffuse out radially and 
they extend beyond the disrupted shell. At the same time, an increasing fluorescence 
signal is observed in the background. The particles seem to be still locally concentrated 
even after near-complete degradation of the capsule. This is because the particles are an 
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order-of-magnitude larger compared to the liposomes, which ensures that their diffusion 





Figure 3.5. Release of fluorescent microparticles from self destructing “motherships” 
(chitosanase:1.5 units/mL): (a) Initial, fluorescent particles contained within capsule;    
(b) after 3 h, capsule showing partial degradation with release of a few microsparticles; 
(c) after 4 h, increasing background fluorescence; (d) after 5 hours, fluorescent particles 







3.3.3. STORAGE OF SELF DESTRUCTING MOTHERSHIPS 
Our self-destructing mothership capsules start degrading as soon as they are 
placed in buffer solution. For use in various applications, it would be preferable if we 
could delay the “clock” for starting the enzymatic self-destruction sequence. Towards this 
end, we explored whether these capsules could be freeze-dried and stored, and whether 
they would still be active when re-hydrated. Figure 3.6 shows that this is indeed the case. 
We took freshly prepared mothership capsules (Figure 3.6a) and immediately subjected 
them to freeze drying under mild conditions. Dehydrated capsules collapsed to a dry 
powder (Figure 3.6b), allowing for convenient storage. Subsequently, the freeze-dried 
capsules were reconstituted by hydrating with a pH 6 buffer solution. Hydration caused 
the capsules to regain their original form, as shown in Figure 3.6c. Additionally, capsules 
retained their self-destructing nature and underwent degradation as expected (Figure 
3.6d). Control capsules without enzyme could also be rehydrated after freeze-drying, but 
did not undergo any degradation. Thus, by employing a simple freeze-drying method, we 





Figure 3.6. Storage of mothership capsules (a) Freshly prepared mothership capsules; (b) 
Capsules in powdery form after freeze drying; (c) Micrograph of reconsituted capsule in 
buffer; (d) Reconstituted capsule undergoing degradation. The scale bar in images (c) & 
(d) equal 1 mm. 
 
3.3.4. EXTERNAL DEGRADATION OF MOTHERSHIPS BY ENZYMES 
Finally, it is worth pointing out that our mothership capsules can also be degraded 
using enzymes from the outside. That is, if instead of packaging these capsules with 
enzymes, we added enzyme to the external solution, the added enzyme would indeed 
trigger the degradation of the capsules. Such enzyme-induced breakdown can be made to 
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occur for capsules with either a gellan or a chitosan core. We should point out that the 
self-destructing capsules could not be made with a chitosan core, i.e., the enzyme was not 
active if placed in a chitosan core. That is why we packaged the enzymes in a gellan gum 
core and with chitosan forming the shell. However, consider the results in Figure 3.7, 
which are for vesicle-bearing mothership capsules with a chitosan core and a gellan shell 
(note the bluish color of the capsules in Figure 3.7a, which arises due to light scattering 
from the vesicles). These capsules were placed in a buffer solution and to this solution we 
introduced 3 units/mL of chitosanase. Initially, the capsule remained intact but started to 
degrade after 1 day. Over the next 2 days, the capsule continued to degrade, as can be 
seen from the photo at the end of 3 days (Figure 3.7b). The capsules were completely 
broken at the end of 5 days (Figure 3.7c), and the debris from the broken capsules was 
mostly dissolved, leaving behind a clear solution.  
 
 
Figure 3.7. Capsules (chitosan core, gellan shell) under attack of chitosanase (3 
units/mL) placed in external buffer solution. (a) initial, intact capsules with internalized 
vesicles, (b) 3 days, debris from degraded capsules (c) 5 days, note the bluish tinge in the 
clear solution due to intact vesicles scattering light.  
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Note that in this case, the chitosanase enzyme is degrading not just the shell, but 
presumably also the chitosan in the core of the capsules. For this reason, the degradation 
process takes a longer time (days) than in the case of gellan-core capsules, where the 
chitosan is present only in the shell. Also, when DLS was performed on this solution, 
structures approximately 100 nm in size were detected, which are evidently intact 
vesicles released from the capsules. Overall, we have thus established that mothership 
capsules can not only self-destruct due to internal enzyme, but also be induced to open up 
due to external enzymes.  
 
3.4. CONCLUSIONS 
We have synthesized mothership capsules, which are polymeric container 
structures that encapsulate much smaller babyships, i.e., vesicles. A simple, single-step 
method is used to generate these capsules under mild conditions. Additionally, we 
designed motherships that can self-destruct due to an encapsulated enzyme. The enzyme 
breaks down the capsule shell and thereby allows the vesicles to escape intact. Capsule 
degradation time can be tuned by the concentration of encapsulated enzyme.  These 
motherships can be stored as an inert, freeze-dried powder until required; when 
reconstituted with buffer, they continue to have their self-destructing property. We 
believe that such capsules have great potential for delivery of a variety of payloads 
including drugs, biological therapeutics, cosmetics, or flavor ingredients. 
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Chapter 4: CONCLUSIONS & RECOMMENDATIONS 
 
4.1. CONCLUSIONS  
In this thesis, we have assembled hierarchical “mothership” structures 
encapsulating “babyship” vesicles inside them. We have developed a single step method 
to form such hybrid structures by employing a simple coacervation technique. We have 
internalized babyship vesicles within the lumen of the mothership capsules by employing 
an easy encapsulation technique. An advantage of our system is that we have utilized 
mild settings, avoiding the use of extreme conditions or harsh solvents for capsule 
preparation.  
 
We have then demonstrated the destruction of these mothership capsules by 
employing enzymes as stimuli and ensured the delivery of intact vesicles to the target. By 
internalizing the enzyme within the capsule lumen, we confer self destructing properties 
to these “mothership” capsules. Finally, we have demonstrated a simple method to store 
these self destructing capsules for future applications. We visualize self destructing 
“mothership” capsules analogous to ticking time bombs with an internal trigger to deliver 
encapsulated drugs at a targeted time. We believe that such structures have significant 
advantages as well as potential uses in drug delivery systems. Such structures can be 
useful to a variety of applications such as delivering biological therapeutics, cosmetics, 




4.2. FUTURE DIRECTIONS 
For future studies we could load vesicles with model drugs and monitor release 
profiles as a function of enzyme concentration. This would give us a better understanding 
of degradation kinetics of the capsule. The ultimate goal would be to develop an 
empirical equation which would enable us to calculate the degradation time. Investigation 
of other factors affecting degradation time such as molecular weights of polymers, 
different strains of enzymes and reaction conditions would be helpful in this direction. 
 
Mothership capsules could also be tested for in-vivo applications. We could study 
the uptake of drug laden liposomes by cells when released by “mothership” capsules. 
Another direction to take in the future would be to develop capsules at the microscale. 
This can be done by employing processes such as microfluidics or atomization. This 
would enhance the utility of the mothership capsules. 
 
We could also attempt make modification to the current system to bring about 
changes in degradation kinetics. For example, hydrophobically modified chitosan could 
be used as the cationic polymer which would offer stearic hindrance to enzyme attack and 
thereby increase degradation time. Alternatively, we could use two enzymes within the 
system, degrading both polymers to hasten the delivery of vesicles. It would also be 
beneficial to extend this concept and explore other systems and polymers to prepare and 
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